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Abstract 
It has been previously shown that activation of PKCα on the leading edge 
membrane of a polarized chemotaxing cell contributes to a positive feedback loop that 
sustains leading edge formation and facilitates eukaryotic cell movement. As a result of 
its vital role in this process and other known signaling pathways, PKCα has been studied 
to better understand both normal cell function and the various diseases in which PKCα is 
an important player, including cancer. A recent single molecule study on PKCα has 
shown that, once bound to the membrane bilayer, the PKCα C1B domain plays a critical 
role in the final step of kinase activation on the target membrane. Specifically, C1B is 
recruited to the membrane by its binding to the activating lipid diacylglycerol (DAG) to 
activate the kinase. However, the key interactions of C1B with the lipid bilayer and its 
known lipid activators including DAG and phorbol esters are still under investigation. In 
this study, EPR site-directed spin labeling and power saturation measurements were 
employed to determine membrane insertion depth values for the PKCα C1B domain on 
simple lipid bilayers containing PC and PS in the presence and absence of known lipid 
activators DAG and PMA (the latter a phorbol ester). These depth values were then 
compared to protein-to-membrane depth values previously obtained through molecular 
dynamic (MD) simulations of the C1B domain by others, and to diffusion rates 
previously measured for C1B bound to the same lipid mixtures by others. All three 
approaches yielded a common trend in binding depths for C1B, indicating that C1B 
adopts a shallow docking depth when bound to PMA and a deeper docking depth when in 
a membrane-bound, activator-free state or bound to DAG on the lipid membrane bilayer. 
The present EPR-determined membrane depths provide the most direct measure of this 
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shallower docking geometry on PMA-containing membranes. The shallow geometry may 
well play an important role in the higher affinity of C1B for PMA compared to DAG, 
where additional membrane penetration may have an energetic cost.  The higher affinity 
for PMA superactivates PKCα and plays a central role in well established ability of 
phorbol esters to promote tumor formation. 
 
Introduction 
 Eukaryotic cells, such as white blood cells, employ chemotactic signaling 
processes to direct cell movement and seek foreign bacteria. Chemotaxis is the response 
of a cell to an extracellular chemical gradient to direct cell movement. This process is 
vital for the development of multicellular organisms and facilitates many cell functions, 
like the ability of macrophages to fight invading bacteria. In the chemotactic signaling 
pathway, an extracellular chemical attractant will activate a transmembrane receptor, like 
a G-protein coupled receptor or receptor tyrosine kinase. The signal is transduced to other 
intracellular proteins and second messengers involved in a positive feedback loop 
resulting in actin polymerization, extension of the filamentous cellular cytoskeleton, and 
the forward growth of lamellipodia up the attractant gradient, yielding amoeboid-like 
movement toward its target.7  
 Key components of the positive feedback loop initiated by transmembrane 
receptor activation have been identified. Phosphoinositide 3 Kinase (PI3K) activity is 
essential for cell polarization, which creates the leading edge region of the cell where 
receptor activation triggers second messenger release and lamellipodia formation during 
chemotaxis.1 F-actin polymerization and a leading edge Ca2+ signal are other crucial 
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feedback loop components.1 Ca2+ triggers membrane localization of the serine/threonine 
kinase Protein Kinase C α (PKCα) C2 domain to the inner leaflet of the plasma 
membrane on the leading edge of a leukocyte.1, 2   The PKCα C2 domain binds 
phosphatidylserine (PS) plus phosphatidylinositol-4, 5-bisphosphate (PIP2) and PKCα 
subsequently deploys the C1A domain to the membrane (Figure 1).3, 4, 5, 6  C1A then binds 
diacylglycerol (DAG) if available, which triggers C1B binding to the membrane to bind 
the lipid activator. DAG is locally enriched on the inner leaflet of the leading edge 
membrane by conversion of PIP2 to DAG and inositol-1,4,5-trisphosphate (IP3) by 
Phospholipase C.7  C1B binding to DAG is the crucial final step that triggers the 
activation of the PKCα kinase.3  Activated PKCα is another essential component of the 
leading edge positive feedback loop and has downstream targets such as the membrane 
cytoskeleton protein Vinculin that contributes to anchoring F-actin to the membrane.1, 8  
 
Figure 1. This figure has been adapted from Ziemba et al. (2014).3 (A) The protein domain organization of 
the conventional Protein Kinase C α. P is a small inhibitory pseudo-substrate peptide followed by two 
tandem C1 domains, C1A and C1B. The C2 domain is a Ca2+ activated domain that localizes PKCα to the 
membrane. (B) The current working model for PKCα activation. The C2 domain is Ca2+ activated and 
translocates to the plasma membrane where it initially binds phosphatidylserine (PS) (II). A PS lipid is 
exchanged for phosphatidylinositol-4, 5-bisphosphate (PIP2) (III) and then C1A domain binds the 
membrane (IV) resulting in bound, inactive kinase.  Kinase activation occurs upon C1B binding to DAG.  
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A recent single molecule total internal reflection fluorescence (SM-TIRF) 
microscopy study by Ziemba et al. (2014) has greatly contributed to our knowledge of 
PKCα’s mechanism of activation. By measuring diffusion constants of several PKCα 
constructs on supported lipid bilayers of various lipid compositions, this study brought 
attention to the previously unknown activation state intermediate (Figure 1B, state IV) 
with C1A deployed to the membrane prior to the DAG signal, revealing that the DAG-
triggered recruitment of C1B to the membrane was the final key step in PKCα kinase 
activation.3 A molecular dynamics (MD) simulation study by Li et al. (2014) helped 
further understand the complex interactions of C1A and C1B on simple membrane 
bilayers containing known PKC activator lipids phorbol 12-myristate 13-acetate (PMA) 
and DAG.9 By using a large amount of computing power one is able to simulate the 
interactions between a C1 domain and its target membrane. This MD study helped shed 
light on the electrostatic interactions of C1A/C1B with the anionic lipid PS. It also gave a 
detailed description of the hydrogen-bonding network and hydrophobic contacts that 
govern interactions between C1A and C1B with known lipid activators. The hydrogen-
bonding network involved in C1B interactions with both PMA and DAG was shown to 
be identical, each involving amino acid residues T113, L122, and G124.9 However, PMA 
has been shown to have a much higher binding affinity than DAG for the PKCα C1B 
domain and PMA has been shown to be a superior activator of PKCα relative to DAG.3, 10 
Molecular dynamics (MD) simulations are an essential technique and can provide 
very useful information about the system being studied.  If possible, in silico simulations 
should be paired with in vitro experiments to increase the predictive power of the 
simulations and ultimately verify the information obtained. The current study aims to test 
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the modeled C1B-membrane orientations from MD simulations using an Electron 
Paramagnetic Resonance (EPR) site-directed spin labeling and power saturation 
measurements. This technique was previously employed in tandem with MD experiments 
to elucidate the binding geometry and docking depth of the PKCα C2 domain and other 
C2 domains.4, 5, 6 
 
Materials and Methods 
Reagents. 
Synthetic lipids phosphatidylcholine (POPC, PC, 1-Palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine), phosphatidylserine (POPS, PS, 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoserine), diacylglycerol (DAG, 1,2-dioleoyl-sn-glycerol) and DOPIP3 
(1,2-dioleoyl-sn-glycero-3-phospho-(19-myo-inositol-39,49,59-trisphosphate)) were 
purchased from Avanti Polar Lipids (Alabaster, AL). MTSSL spin labeled lipids 5-Doxyl 
PC (1-palmitoyl-2-stearoyl-(5-doxyl)-sn-glycero-3-phosphocholine), 7-Doxyl PC (1-
palmitoyl-2-stearoyl-(7-doxyl)-sn-glycero-3-phosphocholine), 10-Doxyl PC (1-
palmitoyl-2-stearoyl-(10-doxyl)-sn-glycero-3-phosphocholine), and 12-Doxyl PC (1- 
palmitoyl-2-stearoyl-(12-doxyl)-sn-glycero-3-phosphocholine) were also purchased from 
Avanti Polar Lipids (Alabaster, AL). Phorbol 12-myristate 13-acetate (PMA) was 
purchased from Sigma-Aldrich (St. Louis, MO). Amylose affinity resin was purchased 
from New England Biolabs (Ipswich, MA). The MTSSL spin label (1-Oxyl- 2,2,5,5-
tetramethyl-D3-pyrroline-3-methylmethanethiosulfonate) was purchased from Toronto 
Research Chemicals (Toronto, Canada). NiEDDA (Ni2+-ethylenediamine diacetic acid) 
was prepared using previously established protocols.4, 11, 12 Beta-Mercaptoethanol (B-ME) 
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was purchased from Fluka (Buchs, Germany). DTT (Dithiothreitol) was purchased from 
Research Product International Corp. (Mount Prospect, IL). DNA segments were 
obtained from Integrated DNA Technologies (Coralville, Iowa). The MTSSL-labeled 
GRP1-PH K282C mutant was from a previous study.11 
Protein Mutagenesis, Expression, Purification and Spin Labeling. 
A previously tested C1B-Maltose Binding Protein (MBP) construct (PKCα 
residues 90-165) with an eleven amino acid recognition sequence for Sfp 
phosphopantethienyl-transferase incorporated into the linker region was used as the base 
construct for cysteine site directed mutagenesis.3 C1B-pMAL-c2X plasmids were 
extracted from E. coli Rosetta 2 (DE3) cells (Novagen) using a Plasmid Mini Prep Kit 
(Omega Bio-tech). Single exposed cysteine mutants were generated via polymerase chain 
reaction using complementary primer oligonucleotides with the incorporated mutations. 
Chemically competent BL21 (DE3) cells were then co-transformed with C1B-pMAL-
c2X and Rosetta 2 plasmids that conferred ampicillin and chloramphenicol resistance 
respectively. C1B mutant sequences were verified (Genewiz) using the M13F(-21) 
primer sequence.  
Cells were grown in Luria Broth (LB) containing ampicillin (100 µg/mL) and 
chloramphenicol (34 µg/mL) overnight at 37°C. Overnight cells were used in a 1:100 
dilution to inoculate new LB containing 11 mM glucose, ampicillin (100 µg/mL), and 
chloramphenicol (34 µg/mL). The new broth was shaken at 37°C until an OD600 between 
0.2 and 0.4 was reached. Cells were then induced with 0.5 mM Isopropyl Beta-D-1 
thiogalactopyranoside (IPTG) to initiate protein expression and shaken at 20°C for 12 
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hours to maximize protein expression.  
Cells were pelleted at 8000 rpm in a Sorvall GS3 Rotor in a RC-5C Plus 
centrifuge and resuspended in Suspension buffer (20 mM Tris-HCl pH 7.4, 25% sucrose, 
2 mM MgCl2). Cells were lysed with chicken egg white lysozyme (Sigma) and incubated 
with Detergent buffer (20mM Tris-HCl pH 7.5, 0.2 M NaCl, 1% Doxycholic acid, 1% 
NP-40) for 30 minutes. Phenylmethanesulfonyl fluoride (PMSF; 1mM) was added and 
samples were sonicated with a Misonix XL 2020. MgCl2 (10mM) and Benzonase (~1 kU) 
were added to digest DNA. Lysate was clarified by spinning at 15,000 rpm in a Sorvall 
SA-600 rotor and flowed through Amylose affinity resin.  To remove unbound protein, 
nucleic acids, and cellular debris, resin was washed extensively with Binding buffer (20 
mM Tris-HCl pH 7.0, 150 mM NaCl, 10 uM ZnCl2, 0.01% w/v Triton-X100) plus 1 mM 
DTT. In preparation for Spin Labeling with MTSSL, Binding buffer plus 5 mM BME 
was added.  BME was then removed with Binding buffer. MTSSL was added to the 
amylose resin column in a 20:1 ratio (label:protein) and incubated overnight at 25°C. To 
elute bound MTSSL-labeled MBP-C1B, amylose resin was incubated with Binding 
Buffer plus 10 mM Maltose for 10 minutes at 25°C. Finally, the eluted protein was 
concentrated using a 30 kD Ultracel Centrifugal Filter (Amicon), prewashed with 
Binding buffer, and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) was used to assess purity.  
Preparation of Liposomes. 
 Lipid vesicles for EPR experiments were formulated to have an end concentration 
of 120 mM. POPC:POPS (PCPS) mixture was 75:25. POPC:POPS:DAG was 74:24:2 
 11 
(DAG) and POPC:POPS:PMA (PMA) was 74:24:2. Doxyl Lipid Standards were 
POPC:POPS:X-Doxyl in the ratio 74.25:24.75:1. Reproduced work with the GRP1-PH 
domain protein standard used the lipid composition POPC:POPS:POPIP3 in the ratio 
74:24:2.11 All lipid compositions were mixed in a combination of 
chloroform:methanol:water, 1:2:0.8 mole ratio, and the solvent was removed by vacuum. 
Lipid films were rehydrated in FB6 buffer (25 mM HEPES (N-(2-hydroxyethyl) 
piperazine-N9-2 ethanesulfonic acid), pH 7.4, with KOH, 140 mM KCl, 15 mM NaCl, 
and 0.5 mM MgCl2) and sonicated with Misonix XL 2020 to generate small unilamellar 
vesicles (SUVs). Lipids were allowed to equilibrate on ice for 1 hour before use.  
EPR Power Saturations and Spectra. 
 All EPR measurements in this study were acquired on the Bruker ELEXSYS 
E500 spectrometer (9.4 Ghz) with a loop gap resonator (Molecular Specialties, Inc.). Spin 
labeled protein samples between 50 and 100 μM were tested on the various lipid 
compositions described above. EPR spectra were collected from one continuous 15-
minute scan at 100 gauss for the doxyl lipid standards and the GRP1-PH domain. 150 
gauss spectra were collected for the C1B mutants. 
 Power saturation measurements were performed on each sample under three 
different conditions: 1) equilibration with N2(g), 2) equilibration with air (20% O2(g)), 
and 3) equilibration with N2(g) and 10mM NiEDDA(aq). All saturations were fit with 
Equation 16: 
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App is the peak-to-peak amplitude of the spectra, P is the power at which the scan 
was collected, and I, P1/2, and ε are parameters fit to the data using a Levenberg-
Marquardt least squares fit. The P1/2 values determined for a sample under each condition 
were then used to calculate collision parameters for each sample with O2(g) and 
NiEDDA(aq) using Equation 26:  
 
Πoxy is the collision parameter of the labeled protein with O2(g) and ΔHpp is the 
average width between the two spectra peaks (lowest peak and highest peak). P1/2(DPPH) 
and ΔHpp(DPPH) refer to a standardized saturation process. However, all 3 measurements 
on a given sample were collected on the same day and used to calculate the overall depth 
parameter for the MTSSL probe on the protein using Equation 36: 
 
All three saturation measurements for a sample were performed on the same day 
to eliminate the need to calculate P1/2(DPPH) and ΔHpp(DPPH).  Data used to calculate 
each depth parameter, Φ, was collected in triplicate. 
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 Determination of Membrane Depth Insertion from Measured Depth Parameters. 
Several studies have shown that there is a linear relationship between Φ and the 
position of an EPR-sensitive probe in a lipid bilayer.4, 5, 6, 11, 12  However, this relationship 
deteriorates when approaching the symmetrical center of a lipid bilayer or away from the 
membrane as the probe collides with bulk O2(g) or bulk NiEDDA(aq) concentrations, 
respectively.5  To characterize this linear relationship between Φ and membrane insertion 
depth, various doxylated lipids were used to generate depth parameters at known depths 
within the synthetic membranes used in the study. Additionally, this study employs a 
thoroughly-characterized protein from Chen et al. (2012) to further define and confirm 
this linear relationship.11 The D116C C1B mutant was also tested without lipids to 
establish a Φ value representing a probe that is entirely exposed to NiEDDA(aq). 
Equation 4 was fit to these standardized values using a Levenberg-Marquardt least 
squares fit.5 The resulting curve was used to convert measured Φ values into membrane 
insertion depths relative to the phosphate plane of POPC lipids.  
 
A, B, C, and D are all parameters that are fit to the standardized experimental data 
points and x represents the distance from the phosphate plane of POPC lipids in 
angstroms. A and B represent the linear slope and intercept, respectively. C represents a 
probe distant from the lipid membrane and D reflects the curvature of the fit between the 
bulk NiEDDA aqueous region and the region near the lipid membrane.  
Models of C1B obtained from Li et al. (2014) were modified to incorporate 
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cysteine mutations at D116 and T108 using MacPymol.9 The MTSSL molecules were 
then appended to these cysteine thiols via disulfide bonds (MTSSL Wizard). All rotamer 
positions were then sampled for each MTSSL molecule and the average position of all 
non-clashing rotamers was calculated. The models from Li et al. (2014) were then 
adjusted so that the average MTSSL positions reflected the data collected in this study. 
The distance of the center of mass of C1B was then measured relative to the nitrogen 
plane of POPC lipids to allow for direct comparison with the MD simulation depth 
values. All models presented in this study were generated using MacPymol. 
 
Results 
Strategy for Cysteine Mutation Selection. 
The main goal of this study was to test the proposed binding depths of C1B on 
various lipids as predicted by the published MD simulations of Li et al. (2014).9 In order 
to accomplish this, exposed cysteine mutations needed to be incorporated into the native 
C1B domain to allow the MTSSL spin label to be disulfide linked to the C1B protein 
domain. However, the single cysteine mutations had to be chosen so as not to disrupt the 
native C1B binding to lipid activators. An NMR study by Xu et al. (1997) of the C1B 
domain binding to phorbol dibutyrate was a key source of information in this regard.13 
Residues that were broadened by C1B binding to the phorbol ester were excluded as 
possible candidates. This ruled out the majority of amino acid residues on the twin 
hairpin loops known to constitute the C1B lipid activator binding site. Additionally, 
sequences of conventional PKC isoforms α, βI, βII, and γ were aligned with C1B to 
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identify any non-conserved residues where a cysteine mutation would be least 
detrimental to protein folding and function. Furthermore, MD simulations by Li et al. 
(2014) were valuable in helping avoid potential amino acid mutations that were expected 
to be too distant from the lipid membrane interface to measure a membrane penetration 
depth.9 This analysis yielded the two amino acid candidates D116 and T108 for cysteine 
point mutations (Figure 2).  These positions were predicted by the MD simulation to be 
close enough to the membrane to enable interpolation of their bilayer proximities from 
the information provided by spin labeled lipids and protein standards.  
 
 
 
                                      
Figure 2. Cysteine mutations on PKCα C1B are shown in red. The left most mutation is D116C and the 
right mutation is T108C. Twin hairpin loops thought to comprise the lipid activator binding site are 
oriented towards the bottom. Residues broadened by binding lipid micelles are shown in cyan and residues 
additionally broadened by phorbol binding are shown in white.13 
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Generating a Lipid Standard Depth Parameter Calibration Curve. 
The doxyl lipid standards containing an EPR sensitive probe at the 5, 7, 10 and 12 
positions on the acyl moiety, together with a protein spin label of known depth on GRP1-
PH domain, were used to generate a membrane depth parameter calibration line.  This 
standard line was used to convert depth parameters into depth distances normal to the 
bilayer within the linear range of the relationship.6 Average spin label positions for 
doxylated lipid standards are depicted on a simulated membrane bilayer (Li and Voth, 
unpublished data) in Figure 8A.  Representative EPR spectra for the four doxyl lipids in 
this study are shown in Figure 3.  Measured depth parameters for doxyl lipid standards 
and their known, experimentally determined membrane depths are presented in Table 1.6 
Additionally, a previously tested MTSSL spin labeled GRP1-PH domain protein from 
Chen et al. (2012) was re-measured in this study to generate an additional standard data 
point near the aqueous membrane interface.  A representative spectrum of the GRP1-PH 
domain standard is shown in Figure 4.11 Finally, the MTSSL-labeled D116C mutant was 
tested in the absence of lipid membranes to measure the most negative depth parameter 
possible for this system (Figure 5). These standardized points defined a best fit curve (see 
Methods) revealing the linear region used to calculate depth values for C1B MTSSL-
labeled D116C and T108C mutants on simple membrane bilayers ± lipid activators DAG 
or PMA (Figure 7). All measured depth parameters and their interpolated membrane 
insertion depths are shown in Table 1.  
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Figure 3. Spectra obtained for doxyl lipid standards are 100 gauss scans taken continuously over one 15-
minute interval. Lipid compositions were POPC:POPS:X-Doxyl Lipid in the ratio 74.25:24.75:1. Spectra 
have been normalized with respect to the area under each curve and baseline corrected. 
 
 
 
                  
Figure 4. Spectra obtained for the MTSSL-labeled GRP1-PH K282C mutant on lipid membranes with the 
composition POPC:POPS;POPIP3 in the ratio 74:24:2. The spectrum is a 100 gauss scan taken 
continuously over one 15-minute interval. Spectra have been normalized with respect to the area under 
each curve and baseline corrected. 
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Determining Mutant Depth Parameters. 
 Single cysteine mutant C1B proteins were individually generated, labeled with 
MTSSL spin label and tested on lipids containing PCPS, PC/PS/DAG, and PC/PS/PMA 
to yield measured depth parameters. Spectra were collected for each mutant on each type 
of lipid membrane and are shown in Figures 5 and 6. The standard calibration curve 
(Figure 7) was used to derive positions relative to the phosphate plane from the measured 
depth parameters. These values are shown in Table 1. 150 gauss scans were taken for the 
C1B mutants as opposed to 100 gauss scans to enable detection of spin-spin interactions. 
 
 
              
Figure 5. Spectra obtained for the PKC alpha C1B D116C mutant labeled with MTSSL on lipid 
membranes with the compositions: POPC:POPS (PCPS) in the ratio 75:25, POPC:POPS:DAG (DAG) in 
the ratio 74:24:2, and POPC:POPS:PMA (PMA) in the ratio 74:24:2. The top left spectrum depicts the 
MTSSL-labeled C1B D116C mutant in the absence of membranes and has had a scaled free label spectra of 
MTSSL (spectrum not shown) subtracted from it to account for free label. The spectra are 150 gauss scans 
taken continuously over one 15-minute interval. Spectra have been normalized with respect to the area 
under each curve and baseline corrected. There is noted spin-spin broadening in the MTSSL-D116C C1B 
mutant in the absence of lipid membranes, top left spectrum. 
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Figure 6. Spectra obtained for the MTSSL-labeled T108C C1B mutant on lipid membranes with the 
compositions: POPC:POPS (PCPS) in the ratio 75:25, POPC:POPS:DAG (DAG) in the ratio 74:24:2, and 
POPC:POPS:PMA (PMA) in the ratio 74:24:2. The top left spectrum depicts the C1B T108C mutant in the 
absence of membranes and has had a scaled free label spectra of MTSSL (spectrum not shown) subtracted 
from it to account for free label.  The spectra are 150 gauss scans taken continuously over one 15-minute 
interval. Spectra have been normalized with respect to the area under each curve and baseline corrected. 
There is noted spin-spin broadening in the MTSSL-T108C C1B mutant in the absence of lipid membranes, 
top left spectrum. 
 
 
Figure 7. Equation 4 (see Methods) was used to analyze the four doxyl lipid standards and the two protein 
standards using a Levenberg-Marquardt least squares fit with R2=0.9957. Values are as follows: A= 0.1560, 
B=0.5370, C=-2.413, D= 0.001377. The lipid standards are shown as red X’s and the GRP1-PH protein 
standard is shown as a red empty circle. The D116C C1B protein standard in the absence of membranes is 
not shown. A positive distance on the x-axis corresponds to a position within the lipid bilayer. The 
measured depth parameter values for the C1B mutants on PCPS/DAG membranes are pink diamonds. C1B 
mutants on PCPS/PMA membranes are blue triangles and C1B mutants on PCPS membranes are filled 
green circles. Error bars are the standard deviations of measurements taken in triplicate. 
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Table 1. The depth parameters and the known distances of the MTSSL labels relative to the phosphate 
plane of phosphatidylcholine (PC) are presented for all doxyl lipids tested and the GRP1-PH mutant 
K282C. The depth parameters and calculated distances of the MTSSL spin label from the phosphate plane 
are presented for both C1B mutants on the various lipids. Errors are the standard error of the mean and are 
displayed where applicable.  
Name 
Depth 
Parameter 
Value 
Error on Depth 
Parameter Value 
Distance from 
Phosphate Plane of PC 
(Å) 
Error on 
Distance (Å) 
15 Doxyl 1.970 0.0370 8.1 - 
7 Doxyl 2.256 0.0121 10.5 - 
10 Doxyl 2.541 0.0158 14 - 
12 Doxyl 3.087 0.0327 16 - 
GRP1-PH 
K282C 1.115 0.0839 4.5 - 
D116C 
APO -2.413 0.0388 - ∞ *
 - 
D116C 
DAG -0.153 0.0602 -4.42 0.390 
D116C 
PMA -0.623 0.0582 -7.44 0.341 
D116C 
PCPS -0.414 0.1682 -6.09 1.074 
T108C 
DAG -0.927 0.0693 -9.39 0.445 
T108C 
PMA -0.777 0.0775 -8.42 0.497 
T108C 
PCPS -0.645 0.1006 -7.58 0.640 
* The D116C C1B mutant was tested in the absence of lipid membranes to measure the most negative 
depth parameter possible for this system and is theoretically an infinite distance away from the phosphate 
plane of POPC lipids. 
 
MTSSL Spin Label Positions and C1B Center of Mass Depths. 
The endpoints of MD experiments from Li et al. (2014) on each of the three 
membranes were used as baseline models.9 The D116C and T108C mutations were 
appended to the initial C1B models and the PyMol MTSSL Wizard plugin was used to 
generate MTSSL labeled protein in silico. All sterically allowed MTSSL chi angles were 
sampled and those that did not result in steric clashes were positionally averaged for each 
spin label position. The position of the oxygen atom containing the radical electron on the 
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averaged MTSSL position is represented as a silver sphere (Figure 8B) and the model 
was shifted to represent the calculated depth measurements relative to the average lipid 
phosphate plane in the MD model. The distance between the C1B center of mass (COM) 
and the nitrogen plane of the PC lipids was then measured to allow for direct comparison 
with the MD simulation depth measurements from Li et al. (2014).9  The three models for 
C1B on PCPS, PCPS/DAG, and PCPS/PMA membranes are depicted in Figure 8B.  
Distances from the C1B COM to the nitrogen plane of phosphatidylcholine lipids are 
shown in Table 2. 
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Figure 8. (A) Colored planes have been aligned with averaged carbon positions in the hydrophobic lipid 
tail of POPC lipids and with the average positions of the phosphate and nitrogen atoms on the hydrophilic 
lipid head groups of POPC lipids. The nitrogen and phosphate planes of POPC lipids are green and white, 
respectively. The upper teal plane, labeled C2 Plane, is aligned with the C2 carbon on the glycerol 
backbone of POPC lipids. The lower teal plane, labeled C2 Plane, is aligned with the C2 carbon on the 
glycerol backbone of POPC lipids on the lower leaflet. The purple plane is aligned with the C5 carbon and 
the yellow plane is aligned with the C7 carbon on the hydrophobic tail. The salmon plane is aligned with 
the C10 carbon and the orange plane is aligned with the C12 carbon. These are the four carbon positions 
that the MTSSL labels are bound to in the four doxyl lipids used to generate the standardized curve in this 
study. (B) The colored planes are the same as in Figure 8A but the POPC and POPS lipids have been 
removed for clarity. The C1B domain has been minimally shifted from the models obtained from the Li et 
al. (2014) MD simulations. The models were translated with respect to the Z-axis and rotated along the axis 
perpendicular to the line connecting the two MTSSL points and perpendicular to the Z-axis. The axis 
parallel to the MTSSL line and perpendicular to the Z-axis was not changed from the base models obtained 
from the MD simulation study. The left most model shows C1B bound to DAG, shown in blue, on 
PCPS/DAG membranes in the orientation representing the measured spin label depths. The middle 
represents C1B on base PCPS membranes and the right model shows C1B on PCPS/PMA membranes. The 
PMA molecule is shown in blue. The oxygen atoms on the averaged MTSSL spin label positions are shown 
as silver spheres and the mutations D116C and T108C are shown in red. Note the shallower position of the 
two hydrophobic twin hairpin loops of C1B on PMA containing membranes. 
 
Table 2. Initial models of the C1B-membrane complex obtained from the Li et al. (2014) MD simulations 
were shifted to be consistent with the average measured MTSSL positions at the D116C and the T108C 
positions. The distance between the COM of C1B and the nitrogen plane of POPC lipids was then 
measured. The errors on these measurements are the standard deviations of the MTSSL depths carried 
through to the COM depth measurements. This error was then converted to the standard error of the mean 
(n=3) since each MTSSL point depth was taken in triplicate and two average MTSSL depths were used to 
calculate each C1B COM depth. COM stands for Center of Mass. The values presented on the right of the 
table are those from the Li et al. (2014) MD simulation study; errors were not provided by the MD 
simulation study.9 
Name Distance of COM to N-plane (Å) 
Distance of COM to N-plane (Å) from MD 
Simulations9 
C1B on 
PCPS/DAG 4.4 + 0.3 3.9 
C1B on 
PCPS/PMA 5.4 + 0.7 4.4 
C1B on PCPS 4.4 + 0.6 4 
 
A 1-tailed 2-sample Student’s t-test was used to compare EPR center of mass 
depths for C1B, each determined by two MTSSL power saturation depth points, on PMA 
and DAG containing membranes, p = 0.10. Similarly, comparing EPR center of mass 
depth values for C1B on PCPS membranes and PCPS/PMA membranes resulted in p = 
0.13. C1B bound to PMA exists in a shallower state that is significant at the p < 0.15 
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level. The difference between center of mass depths for C1B on PCPS and PCPS/DAG 
membranes was not significant.  
A 2-tailed 1-sample Student’s t-test was used to compare EPR center of mass 
depths with MD simulation center of mass depths for C1B on similar membranes. Errors 
were not provided by the Li et al. (2014) MD simulation study so all calculated p values 
are underestimates. Comparing C1B membrane insertion depths in the absence of 
activating lipids, in the presence of DAG, and in the presence of PMA resulted in p 
values equal to 0.57, 0.26, and 0.29, respectively. Differences between the EPR 
membrane insertion depths and the MD simulation insertion depths for C1B on similar 
membranes are not statistically significant at the p < 0.25 level.  
 
Discussion 
Overall, the trends observed in the membrane depth values measured for C1B on 
simple membranes obtained in this EPR site-directed spin label and relaxation study 
agree with the trends in predicted membrane depths provided by the Li et al. (2014) 
molecular dynamic study.9 In both the experimental and computational studies, PMA 
generates the shallowest binding state while the DAG and the activator-free states are 
slightly deeper.  The differences in this EPR study are, however, subtle and at the edge of 
statistical significance, significant at the p < 0.15 level.  
Reassuringly, the same trend of lipid activator-dependent depth of C1B is 
observed in the experimental, single molecule diffusion rates of C1B on the same three 
lipid compositions, as measured by Brian Ziemba in our lab (unpublished) and presented 
in Table 3.  As expected for the shallowest state, the PMA-bound state exhibits the 
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highest average diffusion constant, yielding an average diffusion speed over 2-fold higher 
than that observed for the DAG-bound and activator-free states. This increased diffusion 
speed observed with PMA-bound C1B is statistically significant at the p ≤ 0.0005 level.  
 
Table 3:  Population-weighted average and multi-state analysis of single-molecule TIRF experiments.  
Diffusion constants (square micrometers per second) of C1A and C1B were determined by calculating the 
population-weighted average of diffusion constants from a two-component Rayleigh best fit of each 
protein-lipid data set. Each measurement analyzed at least 1000 diffusion tracks from five experiments (n ≥ 
5).   
Name PC/PS PC/PS/DAG PC/PS/PMA 
C1A  
(state 1) 
1.63 ± 0.26 µm2/s  
(29 ± 2%) 
1.39 ± 0.10 µm2/s  
(30 ± 2%) 
1.4 ± 0.06 µm2/s  
(41 ± 5%) 
C1A    
(state 2) 
0.15 ± 0.02 µm2/s  
(71 ± 2%) 
0.14 ± 0.02 µm2/s  
(70 ± 2%) 
0.15 ± 0.01 µm2/s  
(59 ± 5%) 
C1A Pop-Weightd 
Avg Diffusion 0.58 ± 0.07 µm2/s 0.52 ± 0.03 µm2/s 0.66 ± 0.07 µm2/s 
C1B   
(state 1) 
0.66 ± 0.27 µm2/s  
(61 ± 5%) 
0.99 ± 0.22 µm2/s 
(55 ± 5%) 
1.43 ± 0.02 µm2/s  
(83 ± 3%) 
C1B   
 (state 2) 
0.20 ± 0.12 µm2/s  
(29 ± 5%) 
0.12 ± 0.04 µm2/s  
(44 ± 5%) 
0.21 ± 0.03 µm2/s  
(17 ± 3%) 
C1B Pop-Weightd 
Avg Diffusion 0.48 ± 0.11 µm2/s 0.59 ± 0.18 µm2/s 1.22 ± 0.03 µm2/s 
 
 In summary, the EPR, MD, and diffusion findings reveal an interesting shared 
trend suggesting that C1B shifts to a shallower membrane bound state when bound to 
PMA, relative to the DAG-bound and activator-free states that exhibit similar depths.  
This shift is statistically significant for the diffusion measurements, but is at the edge of 
significance for the EPR measurements.  To further test the significance of this trend by 
EPR, at least two approaches are possible. In the current study, only two C1B positions 
were tested.  The comparison between membrane-bound C1B geometries presented in the 
Li et al. (2014) MD simulations, and the geometries found in this EPR study can be 
enhanced by the addition of a third C1B MTSSL position.  This will enable generation of 
a triangular plane described by the three MTSSL points to more accurately compare 
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experimental and MD simulated C1B orientations and depths.  In addition, the statistical 
significance of the experimentally measured effect of PMA on membrane depth may be 
increased by obtaining more replicate measurements of the average membrane depths to 
reduce the standard errors.  This will also help confirm predictions made by MD and 
single molecule diffusion experiments. Finally, by extending this present EPR analysis to 
C1A, so that the docking depths and geometries of C1A and C1B can be compared, one 
may better understand how PKC C1 domains function to trigger PKC kinase activation 
upon interaction with lipid activators.  Due to the high degree of conservation amongst 
the 26 known phorbol ester binding C1 domains, these findings may extend to other 
proteins of interest.14 
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